Table 3.
Pooled RRs for long-term 10-ppbV incremental O3 exposure-associated mortalities by four major metrics and crude risks without harmonization
| Mortality causes | 6mDMA8 | 6mDA24 | ADMA8 | ADA24 | Crude |
|---|---|---|---|---|---|
| All causes (n = 23) | 1.014 (1.009, 1.019) | 1.023 (1.014, 1.032) | 1.016 (1.010, 1.022) | 1.027 (1.017, 1.037) | 1.017 (1.011, 1.023) |
| Respiratory diseases (n = 16) | 1.025 (1.010, 1.040) | 1.042 (1.016, 1.069) | 1.029 (1.011, 1.047) | 1.049 (1.019, 1.081) | 1.031 (1.017, 1.046) |
| Chronic obstructive pulmonary disease (n = 7) | 1.056 (1.029, 1.084) | 1.098 (1.050, 1.149) | 1.066 (1.034, 1.098) | 1.116 (1.058, 1.176) | 1.055 (1.032, 1.078) |
| Cardiovascular diseases (n = 15) | 1.019 (1.004, 1.035) | 1.033 (1.006, 1.061) | 1.022 (1.004, 1.041) | 1.038 (1.007, 1.071) | 1.024 (1.009, 1.038) |
| Ischemic heart disease (n = 10) | 1.012 (0.987, 1.039) | 1.021 (0.977, 1.067) | 1.014 (0.984, 1.045) | 1.024 (0.973, 1.078) | 1.017 (0.994, 1.041) |
| Congestive heart failure (n = 4) | 1.074 (1.054, 1.093) | 1.130 (1.094, 1.168) | 1.086 (1.063, 1.110) | 1.155 (1.110, 1.198) | 1.083 (1.059, 1.107) |
| Cerebrovascular diseases (n = 6) | 0.993 (0.979, 1.008) | 0.988 (0.964, 1.013) | 0.992 (0.976, 1.009) | 0.986 (0.958, 1.015) | 0.992 (0.979, 1.006) |
| Lung cancer (n = 12) | 0.966 (0.926, 1.007) | 0.943 (0.878, 1.012) | 0.960 (0.915, 1.008) | 0.933 (0.859, 1.014) | 0.960 (0.909, 1.013) |